Principles and Strategies of Antimicrobial Stewardship in the Neonatal Intensive Care Unit

Seminars in Perinatology

Volumn 36, Issue 6, 2012, Pages 431-436

  Patel, Sameer J ^a   Saiman, Lisa ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Antibiotic resistance; Antibiotic stewardship; Patient safety

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE INHIBITOR; METRONIDAZOLE; OXACILLIN; VANCOMYCIN;

ACUTE DRUG ADMINISTRATION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; DECISION SUPPORT SYSTEM; DOSE TIME EFFECT RELATION; DRUG COST; DRUG MONITORING; DRUG SAFETY; EXTREMELY LOW BIRTH WEIGHT; FEEDBACK SYSTEM; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEWBORN INTENSIVE CARE; PATIENT SAFETY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION; VERY LOW BIRTH WEIGHT;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CLINICAL PROTOCOLS; CROSS INFECTION; DRUG MONITORING; DRUG RESISTANCE, MICROBIAL; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MEDICATION THERAPY MANAGEMENT; MICROBIAL SENSITIVITY TESTS; PATIENT CARE TEAM; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PRESCRIPTION DRUG MISUSE;

EID: 84870178758     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2012.06.005     Document Type: Review

References (45)

1. Goldmann D.A., Weinstein R.A., Wenzel R.P., et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: A challenge to hospital leadership. JAMA 1996, 275:234-240.
2. Lesch C.A., Itokazu G.S., Danziger L.H., et al. Multi-hospital analysis of antimicrobial usage and resistance trends. Diagn Microbiol Infect Dis 2001, 41:149-154.
3. Grohskopf L.A., Huskins W.C., Sinkowitz-Cochran R.L., et al. Use of antimicrobial agents in US neonatal and pediatric intensive patients. Pediatr Infect Dis J 2005, 24:766-773.
4. Singh N., Patel K.M., Léger M.M., et al. Risk of resistant infections with Enterobacteriaceae in hospitalized neonates. Pediatr Infect Dis J 2002, 21:1029-1033.
5. Cotten C.M., McDonald S., Stoll B., et al. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006, 118:717-722.
6. Cotten C.M., Taylor S., Stoll B., et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009, 123:58-66.
7. Alexander V.N., Northrup V., Bizzarro M.J. Antibiotic exposure in the new born intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 2011, 159:392-397.
8. Mazzeo F., Capuano A., Avolio A., et al. Hospital-based intensive monitoring of antibiotic-induced adverse events in a university hospital. Pharmacol Res 2005, 51:269-274.
9. McNeeley D.F., Saint-Louis F., Noel G.J. Neonatal enterococcal bacteremia: An increasingly frequent event with potentially untreatable pathogens. Pediatr Infect Dis J 1996, 15:800-805.
10. Stone P.W., Gupta A., Loughrey M., et al. Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiellapneumoniae outbreak in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003, 24:601-606.
11. Gupta A., Della-Latta P., Todd B., et al. Outbreak of extended-spectrum beta-lactamase-producing Klebsiellapneumoniae in a neonatal intensive care unit linked to artificial nails. Infect Control Hosp Epidemiol 2004, 25:210-215.
12. Beck-Sague C.M., Azimi P., Fonseca S.N., et al. Bloodstream infections in neonatal intensive care unit patients: Results of a multicenter study. Pediatr Infect Dis J 1994, 13:1110-1166.
13. Wirtschafter D.D., Padilla G., Suh O., et al. Antibiotic use for presumed neonatally acquired infections far exceeds that for central line-associated blood stream infections: An exploratory critique. J Perinatol 2011, 31:514-518.
14. Accessed April 2, 2012. http://www.who.int/drugresistance/guidance/en/index.html.
15. Dellit T.H., Owens R.C., McGowan J.E., et al. Infectious Diseases Society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44:159-177.
16. Accessed April 1, 2012. http://www.cdc.gov/getsmart/healthcare/.
17. Banerjee S.N., Grohskopf L.A., Sinkowitz-Cochran R.L., et al. Incidence of pediatric and neonatal intensive care unit-acquired infections. Infect Control Hosp Epidemiol 2006, 27:561-570.
18. Franz A.R., Bauer K., Schalk A., et al. Measurement of interleukin-8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: A multicenter, randomized, controlled trial. Pediatrics 2004, 114:1-8.
19. Parravicini E., Nemerofsky S.L., Michelson K.A., et al. Urinary neutrophil gelatinase-associated lipocalin is a promising biomarker for late onset culture-positive sepsis in very low birth weight infants. Pediatr Res 2010, 67:636-640.
20. Malik A., Hui C.P., Pennie R.A., et al. Beyond the complete blood cell count and C-reactive protein: A systematic review of modern diagnostic tests for neonatal sepsis. Arch Pediatr Adolesc Med 2003, 157:511-516.
21. Schelonka R.L., Chai M.K., Yoder B.A., et al. Volume of blood required to detect common neonatal pathogens. J Pediatr 1996, 129:275-278.
22. Connell T.G., Rele M., Cowley D., et al. How reliable is a negative blood culture result?. Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics 2007, 119:891-896.
23. Rubin L.G., Sánchez P.J., Siegel J., et al. Evaluation and treatment of neonates with suspected late-onset sepsis: A survey of neonatologists practices. Pediatrics 2002, 110:e42.
24. Accessed February 12, 2012. http://www.clsi.org/source/orders/free/m39-A3.pdf.
25. Patel S., Landers T., Larson E., et al. Clinical vignettes provide an understanding of antibiotic prescribing practices in neonatal intensive care units. Infect Control Hosp Epidemiol 2011, 32:597-602.
26. Paul M., Benuri-Silbiger I., Soares-Weiser K., et al. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: Systematic review and meta-analysis of randomised trials. BMJ 2004, 328:668.
27. Bliziotis I.A., Samonis G., Vardakas K.Z., et al. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: A meta-analysis of randomized, controlled trials. Clin Infect Dis 2005, 41:149-158.
28. Patel S.J., Delamora P., Zaoutis T., et al. Antibiotic use in neonatal intensive care units and adherence with the centers for disease control and prevention 12-step campaign to prevent antimicrobial resistance. Pediatr Infect Dis J 2009, 28:1047-1051.
29. Kumar Y., Qunibi M., Neal T.J., et al. Time to positivity of neonatal blood cultures. Arch Dis Child Fetal Neonatal Ed 2001, 85:F182-F186.
30. Saito T., Senda K., Takakura S., et al. Detection of bacteria and fungi in BacT/alert standard blood-culture bottles. J Infect Chemother 2003, 9:227-232.
31. Jardine M.A., Kumar Y., Kausalya S., et al. Reducing antibiotic use on the neonatal unit by improving communication of blood culture results: A completed audit cycle. Arch Dis Child Fetal Neonatal Ed 2003, 88:F255.
32. McKamy S., Hernandez E., Jahng M., et al. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children. J Pediatr 2011, 158:422-426.
33. Rybak M.J., Lomaestro B.M., Rotschafer J.C., et al. Therapeutic monitoring of vancomycin in adults. Summary of consensus recommendations from the American Society of Health-System Pharmacists, the infectious Diseases Society of America, and the society of infectious diseases pharmacists. Pharmacotherapy 2009, 29:1275-1279.
34. Accessed January 30, 2012. http://www.premierinc.com/safety/topics/scip/.
35. Amadeo B., Zarb P., Muller A.J., et al. European surveillance of antibiotic consumption (ESAC) point prevalence survey 2008: Pediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J Antimicrob Chemother 2010, 65:2247-2252.
36. Alphonso N., Anagnostopoulos P.V., Scarpace S., et al. Perioperative antibiotic prophylaxis in paediatric cardiac surgery. Cardiol Young 2007, 17:12-25.
37. Gross R., Morgan A.S., Kinky D.E., et al. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001, 33:289-295.
38. Metjian T.A., Prasad P.A., Kogon A., et al. Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J 2008, 27:106-111.
39. Newland J: Clinicians' attitudes towards an antimicrobial stewardship program at a children's hospital. J Pediatr Infect Dis Soc, in press.
40. Patel S.J., Rosen E., Zaoutis T., et al. Neonatologists' perceptions of antimicrobial resistance and stewardship in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2010, 31:1298-1300.
41. Cabana M.D., Rand C.S., Powe N.R., et al. Why don't physicians follow clinical practice guidelines?. A framework for improvement. JAMA 1999, 28:1458-1465.
42. Wilson S.D., Dahl B.B., Wells R.D. An evidence-based clinical pathway for bronchiolitis safely reduces antibiotic overuse. Am J Med Qual 2002, 17:195-199.
43. Valcourt K., Norozian F., Lee H., et al. Drug use density in critically ill children and newborns: Analysis of various methodologies. Prediatr Crit Care Med 2009, 10:495-499.
44. Patel S.J., Saiman L., Duchon J.M., et al. Development of an antimicrobial stewardship intervention using a model of actionable feedback. Interdiscip Perspect Infect Dis 2012, 150367. 2012.
45. Owens R.C., Fraser G.L., Stogsdill P., et al. Antimicrobial stewardship programs as a means to optimize antimicrobial use. Insights from the society of infectious disease pharmacists. Pharmacotherapy 2004, 24:896-908.